Breadcrumb Home Resources and Information Physicians and Scientists Resource Hub Treatment of K562 Cells With ABL Kinase Inhibitors Reveals Differential Metabolic Profiles Treatment of K562 Cells with ABL Kinase Inhibitors Reveals Differential Metabolic Profiles Drug Research , Jan 2026 Renukuntla P et al. Drug Res (Stuttg.), March 2026 Link to full abstract Share Tweet Share Share